Microencapsulated genetically engineered live E. coli DH5 cells administered orally to maintain normal plasma urea level in uremic rats

Nature Medicine

Volumn 2, Issue 8, 1996, Pages 883-887

  Prakash, S ^a   Chang, T M S ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMMONIA; UREA;

AMMONIA BLOOD LEVEL; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIFFUSION; ESCHERICHIA COLI; GENE THERAPY; GENETIC ENGINEERING; KIDNEY FAILURE; MALE; MICROENCAPSULATION; NONHUMAN; PRIORITY JOURNAL; RAT; TREATMENT OUTCOME; UREA BLOOD LEVEL; UREMIA;

ADMINISTRATION, ORAL; AMMONIA; ANIMALS; CAPSULES; DISEASE MODELS, ANIMAL; ESCHERICHIA COLI; FEASIBILITY STUDIES; GENETIC ENGINEERING; KIDNEY FAILURE; KLEBSIELLA PNEUMONIAE; MALE; RATS; RATS, WISTAR; UREA; UREASE; UREMIA;

EID: 0029847820     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0896-883     Document Type: Article

References (38)

1. Griffin, A.M. & Griffin, H.G. Preface, in Molecular Biology: Current Innovations and Future Trends, part 2. (eds. Griffin, A.M. & Griffin, H.G.) 5-6 (Horizon Scientific Press, Norfolk, England, 1995).
2. Mange, A.P. Genetic engineering snowballs. Bioscience 34, 642-643 (1984).
3. Chang, T.M.S. Semipermeable microcapsules. Science 146, 524-525 (1964).
4. Chang, T.M.S. Artificial cells, in Encyclopedia of Human Biology, vol. 1. (ed. Dulbecco, R.) 377-383 (Academic Press, San Diego, California, 1991).
5. Chang, T.M.S. Artificial cells with emphasis on bioencapsulation in biotechnol-ogy. Biotechnol. Annu. Rev. 1, 267-295 (1995).
6. Charles, S., David, M. & Stacia, M. Control of body fluid, electrolyte, and acid-base balance, in Human Physiology: Foundations and Frontiers, (ed. Deborah, A.) 526-527 (Times-Mirror College Publications, St. Louis, Missouri, 1990).
7. Asaba, H. et al. Plasma middle molecules in asymptomatic and sick uremic patients, in Middle Molecules in Uremia and Other Diseases, (ed. Klinkmann, H. et al.) 137-141 (International Society for Artificial Organs, Cleveland, Ohio, 1980).
8. Cohen, B.D. Uremic toxins, in Uremia, an International Conference on Patliogenesis, Diagnosis and Therapy, (eds. Kulte, R., Geoffrey, B. & Benjamin, B.G.) 1-11 (Thieme, Stuttgart, 1972).
9. Kolff, W.J. Artificial kidney and artificial heart: Future considerations. Int. J. Artif. Org. 13, 404-406 (1990).
10. Esposito, R., Carmelo, G & G. Polyhalides. in Sorbents and their Clinical Applications, (ed. Caramelo, G.) 133-153 (Academic Press, London, 1980).
11. Kjellstrand, C., Borges, H, Pru, C., Gardner, D. & Fink, D. On the clinical use of microencapsulated zirconium phosphate-urease for the treatment of chronic uremia. Trans. Am. Soc. Artif. Intern. Org. 27, 24-30 (1981).
12. Drukker, W., Parsons, F.M. & Mahar, J.F. Replacement of Renal Functions by Dialysis. (Martinus Nijhoff, Boston, 1983).
13. Friedman, E.A. Future treatment of renal failure, in Strategy in Renal Failure, (ed. Friedman, E.A.) 521-528 (Wiley, New York, 1978).
14. Sparks, R.E., Saleman, R.M., Meier, P.M., Litt, M.H. & Lindon, O. Binders to remove metabolite from the GI tract. Trans. Am. Soc. Artif. Intern. Org. 18, 458-464 (1972).
15. Sparks, R.E. Review of gastrointestinal perfusion in treatment of uremia. Clin. Kephrol. 11, 81-85 (1979).
16. Walker, J.M., Jacobson, R.L., Stephen, W.J. & Rose, D. The role of adsorbents in the wearable artificial kidney, in Artificial Organs, (ed. Gilchrist, T.) 137-149 (Macmillan Press, London, 1977).
17. Gu, K.F. & Chang, T.M.S. Conversion of alpha-ketoglutarate into L-glutamic acid with urea as ammonia source using multienzyme system and NAD immobilized by microencapsulation with artificial cell in bioreactor. Biotechnol. Bioeng. 32, 363-368 (1988).
18. Gu, K.F. & Chang, T.M.S. Conversion of urea or ammonia into essential amino acids, L-leucine, L-valine and L-isoleucine using artificial cells containing an immobilized multienzyme system and dextran-NAD: Yeast alcohol dehydrogenase for enzyme recycling. J. Biotech. Appl. Biochem. 12, 227-236 (1991).
19. Cattaneo, M. & Chang, T.M.S. The potential of microencapsulated urease-zeolite oral sorbent for the removal of urea in uremia. J. Am. Soc. Artif. Intern. Org. 37, 80-87 (1991).
20. Friedman, E.A., Fastcook, J., Beyer, M.M., Rattazzi, T. & Josephson, A.S. Combined oxystarch-charcoal trial in uremia, sorbent induced reduction in serum cholesterol. Kidney Int. 13, S273-S276 (1976).
21. Agishi, T., Yamashita, N. & Ota, K. Clinical results of direct charcoal hemoperfusion for endogenous and exogenous intoxication, in Hemoperfusion, Part 1, Kidney and Liver Support and Detoxification (eds. Sidemen, S. & Chang, T.M.S.) 255-263 (Hemisphere, Washington, DC, 1980).
22. Prakash, S. & Chang, T.M.S. Microencapsulated genetically engineered E. coli cells containing genes from K. aerogens for urea and ammonia removal. Biomater. Artif. Cells Immobilization Biotechnol. 19, 687-697 (1993).
23. Prakash, S. & Chang, T.M.S. Preparation and in vitro analysis of genetically engineered E. coli DHS cells, microencapsulated in artificial cells for urea and ammonia removal. Biotechnol. Biaeng. 46, 621-626 (1995).
24. Chang, T.M.S. & Prakash, S. Artificial cells and genetically engineered microencapsulated E. coli cells, for urea and ammonia removal, in Methods in Molecular Biology; vol. 63, Expression and Detection of Recombinant Gene, Ch. 75 (ed. Tuan, R.S.) (Humana, Totowa, New Jersey, in the press).
25. Lim, F. & Sun, A.M. Microencapsulated islets as bioartificial pancreas. Science 210, 908-910 (1980).
26. Shian-Soon, P. et al. Insulin independence in a type 1 diabetic patient after encapsulated islet transplant. Lancet 343, 950-951 (1994).
27. Chang, T.M.S. Biotechnology of artificial cells including application to artificial organs, in Comprehensive Biotechnology: The Principle Applications & Regulation of Biotechnology in Industry, Agriculture, and Medicine, (ed. Young, M.M.) 53-73 (Pergamon, New York, 1985).
28. Goosen, A.M. & Mattheus, F.A. Research on animal cell culture in microcapsules. Chem. Eng. Educ. 22, 196-200 (1988).
29. Demetriou, A.A. & Whiting, J.F. Replacement of liver function in rats by trans-plantation of microcarriers-attached hepatocytes. Science 233, 1190-1192 (1986).
30. Demetriou, A.A. Hepatocyte transplantation. Sci. Am. Sci. Med. 1, 58-67 (1994).
31. Saarvedra M.J., Baumann N., Oung, I., Perman, J. & Yolken R.H. Feeding of Bifidobacterium bifidum and Streptococcus thennophilus to infants in hospital for prevention of diarrhea and shedding of rotavirus. Lancet 344, 1046-1049 (1995).
32. Setala, K., Heinonen, H. & Schreck-Purla, I. Ingestion of lyophilized soil bacteria for alleviation of uremic symptoms. IRCS Med. Sci. Nephrol. Urol. 73 (10-97), 35 (1973).
33. Setala, K., Heinonen, H. & Schreck-Purla, I. Uremic waste recovery. Proc. Eur. Dial. Transplant Assoc. 9, 514-520 (1972).
34. Mobley, H.L. & Haussinger, R.P. Microbial ureases: Significance, regulation, and molecular characterization. Microbiol. Rev. 53, 85-108 (1989).
35. Scoot, B., Mulrooney, H. Stuart, P. & Haussinger, R.P. Regulation of gene expression and cellular localization of cloned K. acrogens urease. J. Gen. Microbiol. 135, 1769-1776 (1989).
36. Sambrook, J., Fritsch, E.F. & Maniatis, T. Molecular Cloning: A Laboratory Manual, 2nd edn. (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York, 1989).
37. Marines, F. & White, D.W.R. Immobilization of E. coli expressing the lux gene of Xenorliabdus luminescence. Appl. Environ. Microbiol. 60, 3862-3863 (1994).
38. Symmour, A.C. & Philip, P.C. Colorimetric determination of carbamylamino acids and related compounds. J. Biol. Chem. 209, 145 (1954).